Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary Clinical Trials in Atlanta, Georgia

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial